| Authors: |
Montaño MA; Department of Global Health, University of Washington, Seattle, USA; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, USA; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, USA. Electronic address: mmontano@fredhutch.org., Jatho A; Uganda Cancer Institute, Kampala, Uganda., Nassolo C; Uganda Cancer Institute, Kampala, Uganda., Mugisha N; Uganda Cancer Institute, Kampala, Uganda., Bula A; UNC Project Malawi, Lilongwe, Malawi., Chagomerana MB; UNC Project Malawi, Lilongwe, Malawi; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA., Borok M; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe., Mtisi TJ; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe., Joffe M; Faculty of Health Sciences, Strengthening Oncology Services Research Unit, University of Witwatersrand, Johannesburg, South Africa., Bender Ignacio RA; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, USA; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, USA., Ndlovu N; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe. |
